Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity

Микробиом мышей, получавших пребиотики, выявляет новые мишени, участвующие в ответе организма при ожирении
Patrice François, Patrice D. Cani, Jacques Schrenzel, Nadia Gaïa, Vladimir Lazarević, Fredrik Bäckhed, Nathalie M. Delzenne, Amandine Everard, Marcus Ståhlman, Maria E. Johansson, Maria Johansson
2014-04-03

Reg3g antimicrobial peptidedeep metagenomic sequencinggut microbiomehigh-fat dietprebiotic treatment
The gut microbiota is involved in metabolic and immune disorders associated with obesity and type 2 diabetes. We previously demonstrated that prebiotic treatment may significantly improve host health by modulating bacterial species related to the improvement of gut endocrine, barrier and immune functions. An analysis of the gut metagenome is needed to determine which bacterial functions and taxa are responsible for beneficial microbiota-host interactions upon nutritional intervention. We subjected mice to prebiotic (Pre) treatment under physiological (control diet: CT) and pathological conditions (high-fat diet: HFD) for 8 weeks and investigated the production of intestinal antimicrobial peptides and the gut microbiome. HFD feeding significantly decreased the expression of regenerating islet-derived 3-gamma (Reg3g) and phospholipase A2 group-II (PLA2g2) in the jejunum. Prebiotic treatment increased Reg3g expression (by ∼50-fold) and improved intestinal homeostasis as suggested by the increase in the expression of intectin, a key protein involved in intestinal epithelial cell turnover. Deep metagenomic sequencing analysis revealed that HFD and prebiotic treatment significantly affected the gut microbiome at different taxonomic levels. Functional analyses based on the occurrence of clusters of orthologous groups (COGs) of proteins also revealed distinct profiles for the HFD, Pre, HFD-Pre and CT groups. Finally, the gut microbiota modulations induced by prebiotics counteracted HFD-induced inflammation and related metabolic disorders. Thus, we identified novel putative taxa and metabolic functions that may contribute to the development of or protection against the metabolic alterations observed during HFD feeding and HFD-Pre feeding.
1
COG-based functional metagenomic analysis revealed distinct protein-function profiles among control, prebiotic, high-fat-diet, and combined-treatment groups.
2
High-fat diet and prebiotic treatment produced distinct gut microbiome profiles across multiple taxonomic levels.
3
High-fat diet feeding significantly reduced jejunal expression of the antimicrobial peptides Reg3g and PLA2g2.
4
Prebiotic treatment increased jejunal Reg3g expression by approximately 50-fold and enhanced intectin expression, indicating improved intestinal homeostasis.
5
Prebiotic-induced microbiota changes counteracted high-fat-diet-associated inflammation and metabolic disorders, identifying candidate protective taxa and metabolic functions.

The gut microbiome and intestinal antimicrobial/homeostatic response in mice subjected to prebiotic treatment under control- and high-fat-diet conditions

Prebiotic- and high-fat-diet-induced changes in gut microbiome composition and metabolic functions, and their relationships with antimicrobial peptide expression, intestinal homeostasis, inflammation, and obesity-related metabolic disorders

Publication Details
Publication Date
2014-04-03
Journal
Publisher
ISSN
Cited by
608
Access Type
Author Information
Authors
Patrice François
Patrice D. Cani
Jacques Schrenzel
Nadia Gaïa
Vladimir Lazarević
Fredrik Bäckhed
Nathalie M. Delzenne
Amandine Everard
Marcus Ståhlman
Maria E. Johansson
Maria Johansson
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%